Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide (CPP) technology platform. The Company’s lead product candidate, nomlabofusp, is a subcutaneously administered, recombinant fusion protein intended to deliver tissue frataxin (FXN), an essential protein, to the mitochondria of patients with Friedreich's ataxia (FA). FA is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality. Its CPP platform, which enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets, has the potential to enable the treatment of other rare and orphan diseases. The Company intends to use its proprietary platform to target additional orphan indications characterized by deficiencies in or alterations of intracellular content or activity.
Find out what a historical investment in Larimar Therapeutics Inc would be worth today using our LRMR stock calculator.
Buying LRMR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Larimar Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in LRMR
What is the ticker symbol of Larimar Therapeutics Inc?
The ticker symbol for Larimar Therapeutics Inc is LRMR.
How much is one share of LRMR?
One share of LRMR is valued at $3.22 as of 20 November 2026.
What is the market capitalisation of Larimar Therapeutics Inc LRMR?
As of 20 November 2026 Larimar Therapeutics Inc has a market cap of $337.45M.
What is the 52-week high for Larimar Therapeutics Inc stock?
The Larimar Therapeutics Inc 52-week high stock price is $6.42.
What is the 52-week low for Larimar Therapeutics Inc stock?
The Larimar Therapeutics Inc 52-week low stock price is $1.92.
Can I buy LRMR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LRMR shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LRMR on Stake
Buy LRMR from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of LRMR from only US$10 with fractional shares